JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 35 No. 8 1245-1253
© 1994 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lalonde, D.
Right arrow Articles by Benjamin, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lalonde, D.
Right arrow Articles by Benjamin, C.

Thallium-201-Dipyridamole Imaging: Comparison Between a Standard Dose and a High Dose of Dipyridamole in the Detection of Coronary Artery Disease

Daniel Lalonde, Raymond Taillefer, Raymond Lambert, Guy Bisson, Fadi Basile, Ignacio Prieto and Carole Benjamin

Department of Nuclear Medicine and Division of Cardiovascular Surgery, Hôtel-Dieu de Montréal, Université de Montréal, Montréal, Canada

Correspondence: For correspondence or reprints contact: Raymond Taillefer, MD, FRCP(c), Department of Nuclear Medicine, Hôtel-Dieu de Montréal, 3840 St. Urbain Street, Montréal (Québec), H2W 1T8, Canada.

ABSTRACT

The purpose of this study was to compare two different doses of dipyridamole as a pharmacologic stress test for 201Tl imaging. Methods: Twenty-four patients with significant coronary artery disease (15 had undergone a coronary angiogram and 9 had undergone a previous 201Tl study with a significant lesion) were prospectively studied. Within 1 wk, all patients underwent two 201T-dipyridamole myocardial planar studies, one using a standard dose (STD) and the other, a high dose (HIGH) of dipyridamole. The protocol order was randomly assigned. The STD protocol used a dose of 0.14 mg/kg/min for a duration of 4 min (0.56 mg/kg), and the HIGH protocol used a dose of 0.14 mg/kg min for a duration of 6 min (0.84 mg/kg). The 201Tl was injected 3 min after the end of the dipyridamole infusion. Images, obtained 5 min and 4 hr later, were interpreted (divided into five segments each) by three blinded observers. Results: The STD protocol showed normal, ischemia and scar in 252, 91 and 17 segments, respectively. The HIGH protocol detected 232, 118 and 10 segments, respectively. A side-by-side evaluation was done to evaluate the defect extent subjectively, which was greater with HIGH in 14, equal in six and smaller in four patients. One or more side effects were seen in 14 patients with STD and in 19 with HIGH. Increased heart rate (8 bpm for STD and 19 bpm for HIGH, p < 0.001) was the only significant change seen in the hemodynamic parameters. Conclusion: This preliminary study indicates that a high dose of dipyridamole seems to be safe and can be helpful to increase the sensitivity of 201Tl imaging.

Key Words: thallium-201 • dipyridamole • coronary artery disease




This article has been cited by other articles:


Home page
ANGIOLOGYHome page
R. M. Fleming and L. D. Boyd
High-Dose Dipyridamole and Gated Sestamibi SPECT Imaging Provide Diagnostic Resting and Stress Ejection Fractions Useful for Predicting Extent of Coronary Artery Disease
Angiology, July 1, 2002; 53(4): 415 - 421.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
R. M. Fleming
A Tete-a-Tete Comparison of Ejection Fraction and Regional Wall Motion Abnormalities as Measured by Echocardiography and Gated Sestamibi SPECT
Angiology, May 1, 2002; 53(3): 313 - 321.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1994 by the Society of Nuclear Medicine.